PRINTER'S NO. 1067
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
84
Session of
2021
INTRODUCED BY HANBIDGE, SANCHEZ, LONGIETTI, ISAACSON, HILL-
EVANS, MADDEN, HOWARD, DELLOSO, WARREN, SCHWEYER AND O'MARA,
MARCH 26, 2021
REFERRED TO COMMITTEE ON HEALTH, MARCH 26, 2021
A RESOLUTION
Urging the Department of Health to add cystic fibrosis to Phase
1A for COVID-19 vaccine distribution.
WHEREAS, Cystic fibrosis (CF) is a genetic disease that
causes persistent lung infections and limits an individual's
ability to breathe over time; and
WHEREAS, Individuals with CF experience mutations in the
cystic fibrosis transmembrane conductance regulator (CFTR) gene,
which causes the CFTR protein to become dysfunctional; and
WHEREAS, When the CFTR protein is dysfunctional, it causes
mucus in various organs to become thick and sticky, which clogs
airways and traps germs like bacteria, leading to infections,
inflammation and respiratory failure; and
WHEREAS, For this reason, minimizing contact with germs is a
top concern for individuals with CF, which impacts approximately
35,000 individuals in the United States; and
WHEREAS, Individuals with CF can have a variety of symptoms,
including salty-tasting skin, persistent coughing, frequent lung
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17